Vertex Pharmaceuticals (1VRTX) Revenue
Vertex Pharmaceuticals Revenue
Vertex Pharmaceuticals had a revenue of 3.33B in the quarter ending Jun 30, 2026, with 11.62%. This bring the company's revenue in the last twelve months to 12.62B, Increased 3.01%. In the fiscal year ending Dec 31, 2025, Vertex Pharmaceuticals had annual revenue of 12.07B with 9.57% growth.
- Revenue (ttm)
- 12.62B
- Revenue Growth
- 3.94%
- P/S Ratio
- 10.47
- Revenue/Employee
- EUR 1,886,656
- Employees
- 6,400
- Market Cap
- EUR 126.41B
Revenue Chart
Vertex Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.07B | 1.05B | 9.57% |
| Dec 31, 2024 | 11.02B | 1.15B | 11.66% |
| Dec 31, 2023 | 9.87B | 938.50M | 10.51% |
| Dec 31, 2022 | 8.93B | 1.36B | 17.91% |
| Dec 31, 2021 | 7.57B | 1.37B | 22.06% |
| Dec 31, 2020 | 6.21B | 2.04B | 49.07% |
| Dec 31, 2019 | 4.16B | 1.12B | 36.59% |
| Dec 31, 2018 | 3.05B | 558.95M | 22.46% |
| Dec 31, 2017 | 2.49B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.